StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.21−0.08 (-1.27%)

Close on Nov 17, 2026Market cap $279.58MP/E –Yield –

Agenus revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Agenus's revenue for the twelve months ending Jun 30, 2026 was $132.69M, up 30.5% year over year. For fiscal 2025 it was $114.20M, up 10.4% from the year before. Over ten years it grew 16.5% a year on average. The highest annual figure on record is $295.67M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$114.20M+10.4%
FY2024Dec 31, 2024$103.46M-33.8%
FY2023Dec 31, 2023$156.31M+59.5%
FY2022Dec 31, 2022$98.02M-66.8%
FY2021Dec 31, 2021$295.67M+235.3%
FY2020Dec 31, 2020$88.17M-41.2%
FY2019Dec 31, 2019$150.05M+307.9%
FY2018Dec 31, 2018$36.78M-14.2%
FY2017Dec 31, 2017$42.88M+89.9%
FY2016Dec 31, 2016$22.57M-9.0%
FY2015Dec 31, 2015$24.82M+255.7%
FY2014Dec 31, 2014$6.98M+129.1%
FY2013Dec 31, 2013$3.05M-80.9%
FY2012Dec 31, 2012$15.96M+479.2%
FY2011Dec 31, 2011$2.76M-18.0%
FY2010Dec 31, 2010$3.36M+0.8%
FY2009Dec 31, 2009$3.33M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$34.52M+34.4%
Q1 FY2026Mar 31, 2026$33.74M+40.2%
Q4 FY2025Dec 31, 2025$34.20M+27.5%
Q3 FY2025Sep 30, 2025$30.24M+20.4%
Q2 FY2025Jun 30, 2025$25.69M+9.3%
Q1 FY2025Mar 31, 2025$24.07M-14.1%
Q4 FY2024Dec 31, 2024$26.84M-68.0%
Q3 FY2024Sep 30, 2024$25.11M+3.3%
Q2 FY2024Jun 30, 2024$23.51M-7.1%
Q1 FY2024Mar 31, 2024$28.01M+22.3%
Q4 FY2023Dec 31, 2023$83.80M+195.2%
Q3 FY2023Sep 30, 2023$24.31M+6.8%
Q2 FY2023Jun 30, 2023$25.30M+20.9%
Q1 FY2023Mar 31, 2023$22.90M-11.7%
Q4 FY2022Dec 31, 2022$28.39M+40.1%
Q3 FY2022Sep 30, 2022$22.77M-91.0%
Q2 FY2022Jun 30, 2022$20.93M+95.0%
Q1 FY2022Mar 31, 2022$25.94M+121.4%
Q4 FY2021Dec 31, 2021$20.26M-35.2%
Q3 FY2021Sep 30, 2021$252.95M+1605.5%
Q2 FY2021Jun 30, 2021$10.73M-60.2%
Q1 FY2021Mar 31, 2021$11.72M-22.5%
Q4 FY2020Dec 31, 2020$31.27M-9.4%
Q3 FY2020Sep 30, 2020$14.83M-25.6%
Q2 FY2020Jun 30, 2020$26.95M+71.5%
Q1 FY2020Mar 31, 2020$15.13M-81.1%
Q4 FY2019Dec 31, 2019$34.50M+434.8%
Q3 FY2019Sep 30, 2019$19.94M+55.8%
Q2 FY2019Jun 30, 2019$15.72M-1.1%
Q1 FY2019Mar 31, 2019$79.89M+4783.3%
Q4 FY2018Dec 31, 2018$6.45M-22.8%
Q3 FY2018Sep 30, 2018$12.80M+281.1%
Q2 FY2018Jun 30, 2018$15.90M+277.7%
Q1 FY2018Mar 31, 2018$1.64M-93.9%
Q4 FY2017Dec 31, 2017$8.35M+49.8%
Q3 FY2017Sep 30, 2017$3.36M-24.4%
Q2 FY2017Jun 30, 2017$4.21M–
Q1 FY2017Mar 31, 2017$26.96M–
Q4 FY2016Dec 31, 2016$5.58M–
Q3 FY2016Sep 30, 2016$4.45M–

More Agenus figures

See a number that looks wrong?